Eosinophilia Associated with Clonal T-Cell Proliferation

References

• Gabig T.G. Hypereosinophilic syndrome. Hematology, Basic Principles and Practice, R. Hoffman, E.J. Benz, S.J. Shattil, B. Furie, H.J. Cohen. Churchill Livingstone, New York 1991; 567–571
   Google Scholar
• Campbell H.D., Tucker W.Q.J., Hort Y., Martinson M.E., Mayo G.M., Clutterbuck E.J., Sanderson C.J., Young I.G. Molecular cloning, nucleotide sequence, and expression of gene encoding human eosinophil factor (inter-leukin-5). Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 6629–6633
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y., Suda T., Suda J., Eguchi M., Miura Y., Harada N., Tominaga A., Takatsu K. Purified interleukin-5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 1988; 167: 43–56
   PubMed Web of Science ®Google Scholar
• Rennick D.M., Lee F.D., Yokota T., Arai K., Cantor H., Nabel G.J. A cloned MCGF cDNA encodes a multilineage hemopoietic growth factor; multiple activities of interleukin-3. J. Immunol. 1985; 134: 910–914
   PubMed Web of Science ®Google Scholar
• Metcalf D., Begley C.G., Johnson G.R., Nicola N.A., Vadas M.A., Lopez A.F., Williamson D.J., Wong G.G., Clark S.C., Wang A. Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1986; 67: 37–45
   PubMed Web of Science ®Google Scholar
• Le Beau M.M., Larson R.A., Bitter M.A., Vardiman J.W., Golomb H.M., Rowley J.D. Association of an inversion of chromosome 16 with abnormal marrow eosinophilias in acute myelomonocytic leukemia. N. Engl. J. Med. 1983; 309: 630–636
   PubMed Web of Science ®Google Scholar
• Ema H., Kitano K., Suda T., Sato Y., Muroi K., Ohta M., Yoshida M., Sakamoto S., Eguchi M., Miura Y. In vitro differentiation of leukemic cells to eosinophils in the presence of interleukin-5 in two cases of acute myeloid leukemia with the translocation (8;21)(q22;q22). Blood 1990; 75: 350–356
   PubMed Web of Science ®Google Scholar
• Kobayashi H., Kitano K., Shimodaira S., Ishida F., Saito H., Sonoyama M., Enokihara H., Furuta S. Eosinophilia in myelodysplastic syndrome with a (21;21)(q23;q22) translocation. Cancer Genet. Cytogen. 1993; 68: 95–98
   PubMed Web of Science ®Google Scholar
• Catovsky D., Bernasconi C., Verdonock P.J., Postma A., Hows J., Van der Does-van den Berg A., Rees J.K.H., Castelli G., Morra E., Galton D.A.G. The association of eosinophilia with lymphoblastic leukemia or lymphoma: a study of seven cases. Br. J. Haematol. 1980; 45: 523–534
   PubMed Web of Science ®Google Scholar
• Fermand J.P., Mutjavila M.T., Le Couedic J.P., Tsapis A., Berger R., Modigliani R., Seligmann M., Brouet J.C., Vainchenker W. Role of granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5 in the eosinophilia associated with T-cell lymphoma. Br. J. Haematol. 1993; 83: 359–364
   PubMed Web of Science ®Google Scholar
• Di Biagio E., Sanchez-Borges M., Desenne J.J., Suarez-Chacon R., Somoza R., Acquatella G. Eosinophilia in Hodgkin's disease: a role for interleukin 5. Int. Arch. Allergy Immunol. 1996; 110: 244–251
   PubMed Web of Science ®Google Scholar
• Fauci A.S., Harley J.B., Roberts W.C., Ferrans V.J., Gralnick H.R., Bjorson B.H. The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic and therapeutic considerations. Awn. Intern. Med. 1982; 97: 78–92
   Web of Science ®Google Scholar
• Weller P.F., Bubley G.J. The idiopathic hypereosinophilic syndrome. Blood 1994; 83: 2759–2779
   PubMed Web of Science ®Google Scholar
• O'Shea J.J., Jaffe E.S., Lane H.C., MacDermott R.P., Fauci A.S. Peripheral T-cell lymphoma presenting as hypereosinophilia with vasculitis: clinical, pathologic, and immunologic features. Am. J. Med. 1987; 82: 539–545
   PubMedGoogle Scholar
• Raghavachar A., Fleischer S., Frickhofen N., Heimpel H., Fleischer B. T-lymphocyte control of human eosinophilic granulopoiesis: clonal analysis in an idiopathic hypereosinophilic syndrome. J. Immunol. 1987; 139: 3753–3758
   PubMed Web of Science ®Google Scholar
• Schrezenmeier H., Thome S.D., Tewald F., Fleischer B., Raghavachar A. Interleukin-5 is the predominant eosinophilopoietin produced by T-lymphocytes in hypereosinophilic syndrome. Exp. Hematol. 1993; 21: 358–365
   PubMed Web of Science ®Google Scholar
• Cogan E., Schandene L., Crusiaux A., Cochaux P., Velu T., Goldman M. Clonal proliferation of type 2 helper T-cells in a man with hypereosinophilic syndrome. N. Engl. J. Med. 1994; 330: 535–538
   PubMed Web of Science ®Google Scholar
• Brugnoni D., Airo P., Rossi G., Bettinardi A., Simon H.U., Garza L., Tosoni C., Cattaneo R., Blaser K., Tucci A. A case of hypereosinophilic syndrome is associated with the expansion of a CD3−CD4+ T-cell population able to secrete large amounts of interleukin-5. Blood 1996; 87: 1416–1422
   PubMed Web of Science ®Google Scholar
• Kitano K., Ichikawa N., Mahbub B., Ueno M., Ito T., Shimodaira S., Kodaira H., Ishida F., Kobayashi H., Saito H., Okubo Y., Enokihara H., Kiyosawa K. Eosinophilia associated with proliferation of CD3+4−8−αβ+ T-cells with chromosome 16 anomalies. Br. J. Haematol 1996; 92: 315–317
   PubMed Web of Science ®Google Scholar
• Simon H.U., Yousefi S., Dommann-Scherrer C.C., Zimmermann D.R., Bauer S., Barandun J., Blaser K. Expansion of cytokine-producing CD4+CD8− T-cells associated with abnormal Fas expression and hypereosinophilia. J. Exp. Med. 1996; 183: 1071–1082
   PubMed Web of Science ®Google Scholar
• Limaye A.P., Abrams J.S., Silver J.E., Ottesen E.A., Nutman T.B. Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in Helminth-infected patients. J. Exp. Med. 1990; 172: 399–402
   PubMed Web of Science ®Google Scholar
• Romagnani S. Lymphokine production by human T-cells in disease states. Annu. Rev. Immunol. 1994; 12: 227–257
   PubMed Web of Science ®Google Scholar
• Onishi T., Kita H., Weiler D., Sur S., Sedgwich J.B., Calhoun W.J., Busse W.W., Abrams J.S., Gleich G.J. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am. Rev. Respir. Dis. 1993; 147: 901–907
   PubMed Web of Science ®Google Scholar
• Ying S., Durham S.R., Barkans J., Masuayama K., Jacobson M., Rak S., Lowhagen O., Moqbel R., Kay A.B., Hamid Q.A. T-cells are the principal sourse of interleukin-5 mRNA in allergen-induced rhinitis. Am. J. Respir. Cell Mol. Biol. 1993; 9: 356–360
   PubMed Web of Science ®Google Scholar
• Coffman R.L., Seymour B.W.P., Hudak S., Jackson J., Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 1989; 245: 308–310
   PubMed Web of Science ®Google Scholar
• Dent L.A., Strath M., Mellor A.L., Sanderson C.J. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med. 1990; 172: 1425–1431
   PubMed Web of Science ®Google Scholar
• Bonifer R., Neumann C., Meuer S., Schulze G., Herrmann F. Interleukin 5 expressing allergen-specific T-lymphocytes in patients with house dust mite sensitization: analysis at a clonal level. J. Mol. Med. 1995; 73: 79–83
   PubMed Web of Science ®Google Scholar
• Tsutsui H., Terano Y., Sakagami C., Hasegawa I., Mizoguchi Y., Morisawa S. Drug-specific T-cells derived from patients with drug-induced allergic hepatitis. J. Immunol. 1992; 149: 706–716
   PubMed Web of Science ®Google Scholar
• Rosenberg S.A., Lotze M.T., Muul L.M., Leitman S., Chang A.E., Ettinghausen S.E., Matory Y.L., Skibber J.M., Shiloni E., Vetto J.T., Seipp C.A., Simpson C., Reichert C.M. Observations on the systemic administration of autologeous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med. 1985; 313: 1485–1492
   PubMed Web of Science ®Google Scholar
• West W.H., Tauer K.W., Yannelli J.R., Marshall G.D., Orr D.W., Thurman G.B., Oldman R.K. Constant-infusion interleukin-2 in adoptive immunotherapy of advanced cancer. N. Engl. J. Med. 1987; 316: 898–905
   PubMed Web of Science ®Google Scholar
• Ettinghausen S.E., Moore J.G., White D.E., Platanias L., Young N.S., Rosenberg S.A. Hematological effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients. Blood 1987; 69: 1654–1660
   PubMed Web of Science ®Google Scholar
• Macdonald D., Gordon A.A., Kajitani H., Enokihara H., Barrett A.J. Interleukin-2 treatment-associated eosinophilia is mediated by interleukin-5 production. Br. J. Haematol. 1990; 76: 168–173
   PubMed Web of Science ®Google Scholar
• Van Haelst Pisani C., Kovach J.S., Kita H., Leiferman K.M., Gleich G.J., Silver J.E., Dennin R., Abrams J.S. Administration of interleukin-2 (IL-2) results in creased plasma concentrations of IL-5 and eosinophilia in patients with cancer. Blood 1991; 78: 1538–1544
   PubMed Web of Science ®Google Scholar
• Enokihara H., Furusawa S., Kajitani H., Hamaguchi H., Saito K., Fukuda T., Shishido H. Interleukin 2 stimulates the T-cells from patients with eosinophilia to produce CFU-Eo growth stimulating factor. Br. J. Haematol. 1988; 69: 431–436
   PubMed Web of Science ®Google Scholar
• Enokihara H., Furusawa S., Nakakubo H., Kajitani H., Nagashima S., Saito K., Shishido H., Hitoshi Y., Takatsu K., Noma T., Shimizu A., Honjo T. T-cells from eosinophilic patients produce interleukin-5 with interleukin-2 stimulation. Blood 1989; 73: 1809–1813
   PubMed Web of Science ®Google Scholar
• Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989; 7: 145–173
   PubMed Web of Science ®Google Scholar
• Romagnani S. Human TH1 and TH2 subtypes: doubt no more. Immunol., Today 1991; 12: 256–257
   PubMedGoogle Scholar
• Paul W.E., Seder R.A. Lymphocyte response and cytokines. Cell 1994; 76: 241–251
   PubMed Web of Science ®Google Scholar
• Jaffe J.S., James S.P., Mullins G.E., Braun-Elwert L., Lubensky I., Metcalfe D.D. Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and y-interferon (γ-IFN) in peripheral blood T-cells from patients with allergic eosinophilic gastroenteritis. J. Clin. Immunol 1994; 14: 299–309
   PubMed Web of Science ®Google Scholar
• Desenne J.J., Acquatella G., Stern R., Muller A., Sanchez M., Somoza R. Blood eosinophilia in Hodgkin's disease-A follow-up of 25 cases in Venezuela. Cancer 1992; 69: 1248–1453
   PubMed Web of Science ®Google Scholar
• Abruzzo L.V., Jafe E.S., Cotelingam J.D., Whang-Peng J., Del Duca V.J., Medeiros L.J. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am. J. Surg. Pathol. 1992; 16: 236–245
   PubMed Web of Science ®Google Scholar
• Murata K., Yamada Y., Kamihara S., Atogami S., Tsukasaki K., Morita S., Amagasaki T., Sadamori N., Tomonaga M., Kinosita K.I., Ichimaru M. Frequency of eosinophilia in adult T-cell leukemia/lymphoma. Cancer 1992; 69: 966–971
   PubMed Web of Science ®Google Scholar
• Hattori T., Uchiyama T., Toibara T., Takatsuki K., Uchino H. Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood 1981; 58: 645–647
   PubMed Web of Science ®Google Scholar
• Yamada Y. Phenotype and functional analysis of leukemic cells from 16 patients with adult T-cell leukemia/lymphoma. Blood 1983; 61: 446–453
   Google Scholar
• Uchiyama T., Hori T., Tsudo M., Wano Y., Umadome H., Tamori S., Yodoi J., Maeda M., Sawami H., Uchino H. Interleukin-2 receptor (Tac antigen) expressed on adult T-cell leukemia cells. J. Clin. Invest. 1985; 76: 446–453
   PubMed Web of Science ®Google Scholar
• Keidan A.J., Catovsky D., Tavares de Castro J., Spry C.J. Hypereosinophilic syndrome preceding T-cell lymphoblastic lymphoma. Clin. Lab. Haematol. 1985; 7: 83–88
   PubMedGoogle Scholar
• O'Shea J.J., Jaffe E.S., Lane H.C., MacDermott R.P., Fauci A.S. Peripheral T-cell lymphoma presenting as hypereosinophilia with vasculitis. Clinical, pathologic, and immunologic features. Am. J. Med. 1987; 82: 539–545
   PubMedGoogle Scholar
• Kim C.J., Park S.H., Chi J.G. Idiopathic hypereosinophilic syndrome terminating as disseminated T-cell lymphoma. Cancer 1990; 67: 1064–1069
   Web of Science ®Google Scholar
• Bagot M., Bodemer C., Wechsler J. Non epidermotropic T lymphoma preceded for several years by hypereosinophilic syndrome. Ann. Dermatol. Venereol. 1990; 117: 883–885
   PubMed Web of Science ®Google Scholar
• Mraillon I., Bagot M., Bournerias I., Prin L., Wechsler J., Revuz J. Hypereosinophilic syndrome with pachyderma preceding lymphoma: treatment with interferon alpha. Ann. Dermatol. Venereol. 1991; 118: 883–885
   PubMed Web of Science ®Google Scholar
• Pandolfi F.P., Foa R., De Rossi G., Zambello R., Chisesi T., Di Celle P.F., Migone N., Casorati G., Csarselli E., Ensoli F., Trentin L., Semenzato G. Clonally expanded CD3+, CD4− CD8− cells bearing the αβ or the γ/δ T-cell receptor in patients with the lymphoproliferative disease of granular lymphocytes. Clini. Immunol. Immunop. 1991; 60: 371–383
   PubMedGoogle Scholar
• Oshimi K., Yamada O., Kaneko T., Nishinarita S., Iizuka Y., Urabe A., Inamori T., Asano S., Takahashi S., Hattori M., Naohara T., Ohira Y., Masuda Y., Okubo Y., Furusawa S., Sakamoto S., Omine M., Mori M., Tatsumi E., Mizoguchi H. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993; 7: 782–788
   PubMed Web of Science ®Google Scholar
• Kusunoki Y., Hirai Y., Kyoizumi S., Akiyama M. Evidence for in vitro clonal proliferation of unique proliferation of blood CD4−/CD8 T-cells bearing T-cell receptor α and β chains in two normal men. Blood 1992; 79: 2965
   PubMed Web of Science ®Google Scholar
• Dellabona P., Casorati G., Friedli B., Angman L., Sallusto F., Tunnacliffe A., Roosneek E., Lanzavecchia A. In vivo persistance of expanded clones specific for bacterial antigens within the human T-cell receptor α/β CD4−8 subset. J. Exp. Med 1993; 177: 1763
   PubMed Web of Science ®Google Scholar
• Kita H., Ohnishi T., Okubo Y., Weiler D., Abrams J.S., Gleich G.J. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J. Exp. Medi. 1991; 174: 745–748
   PubMed Web of Science ®Google Scholar
• Yousefi S., Hemmann S., Weber S., Holzer C., Hartung K., Blaser K., Simon H.-U. Interleukin-8 is expressed by human peripheral blood eosinophils: evidence for increased secretion in asthma. J. Immunol. 1995; 154: 5481–5490
   PubMed Web of Science ®Google Scholar
• Horie S., Okubo Y., Suzuki J., Isobe M. An emanciated man with eosinophilic pneumonia. Lancet 1996; 348: 166
   PubMed Web of Science ®Google Scholar
• Arthur D.C., Bloomfield C.D. Partial deletion of the long arm of chromosome 16 and bone marrow eosinophilia in acute nonlymphocytic leukemia: a new association. Blood 1983; 61: 994–998
   PubMed Web of Science ®Google Scholar
• Le Beau M.M., Larson R.A., Bitter M.A., Vardiman J.W., Golomb H.M., Rowley J.D. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N. Engl. J. Med. 1983; 309: 630–636
   PubMed Web of Science ®Google Scholar
• Bitter M.A., Le Beau M.M., Larson R.A., Rosnea M.C., Golomb H.M., Rowley J.D., Vardiman J.W. A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13;q22). Am. J. Clin. Pathol. 1984; 81: 733–741
   PubMed Web of Science ®Google Scholar
• Testa J.R., Hogge D.E., Misawa S., Zandparsa N. Chromosome 16 rearrangement in acute myelomonocytic leukemia with abnormal eosinophils. N. Engl. J. Med. 1984; 310: 468–469
   PubMed Web of Science ®Google Scholar
• Campbell H.D., Tucker W.Q., Hort Y., Martinson M.E., Mayo G., Clutterbuck E.J., Sanderson C.J., Young I.G. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). Proc. Natl. Acad. Sci. USA 1987; 84: 6629–6633
   PubMed Web of Science ®Google Scholar
• Liu P., Tarle S.A., Hajra A., Claxton D.F., Marlton P., Freedman M., Siciliano M.J., Collins F.S. Fusion between transcription factor CBFp7PEBP2p and a myosin heavy chain in acute myeloid leukemia. Science 1993; 261: 1041–1044
   PubMed Web of Science ®Google Scholar
• Swirsky D.M., Li Y.S., Mattews J.G., Flemans R.J., Rees J.K.H., Hayhoe F.G.J. 8;21 translocation in acute granulocytic leukemia: Cytological, cytochemical and clinical features. Br. J. Haematol. 1984; 56: 199–213
   PubMed Web of Science ®Google Scholar
• Miyoshi H., Kozu T., Shimizu K., Enomoto K., Maseki N., Kaneko Y., Kamada N., Ohki M. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcripts. EMBO J. 1993; 12: 2715–2721
   PubMed Web of Science ®Google Scholar